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ABSTRACT Genomic DNA clones that coded for the
bifunctional dihydrofolate reductase (DHFR) and thymidylate
synthase (TS) (DHFR-TS) activities from a pyrimethamine-
sensitive strain of Plasmodium falciparum were isolated and
sequenced. The deduced DHFR-TS protein contained 608
amino acids (71,682 Da). The coding region for DHFR-TS
contained no intervening sequences and had a high A+T
content (75%). The DHFR domain, in the amino-terminal
portion of the protein, was joined by a 94-amino acid junction
sequence to the TS domain in the carboxyl-terminal portion of
the protein. The TS domain was more conserved than the
DHFR domain and both P. falciparum domains were more
homologous to eukaryotic than to prokaryotic forms of the
enzymes. Predicted secondary structures of the DHFR and TS
domains were nearly identical to the structures identified in
other DHFR and TS enzymes.
The effective treatment of Plasmodium falciparum malaria
with the antifolate pyrimethamine, a specific inhibitor of
dihydrofolate reductase (DHFR; 5,6,7,8-tetrahydrofolate:
NADP+ oxidoreductase, EC 1.5.1.3) (1), is being compro-
mised by pyrimethamine-resistant (Pyrr) parasites. Pyrr
strains usually contain normal levels of a mutant DHFR with
a reduced affinity for the drug (2-7). The DHFR and
thymidylate synthase (TS; 5,10-methylenetetrahydrofolate:
dUMP C-methyltransferase, EC 2.1.1.45) activities in proto-
zoa often reside on a bifunctional homodimeric polypeptide
(DHFR-TS) (8, 9). DHFR-TS catalyzes the sole biosynthetic
pathway of dTMP and is essential both for DNA synthesis
and for maintaining levels of tetrahydrofolate in P. falcipa-
rum (10).
We describe here the cloning and sequencing of genomic
DNA that encodes the DHFR-TS enzyme of the pyrimeth-
amine-sensitive P. falciparum strain FCR3. We compare the
primary and secondary structures of the DHFR-TS with
known DHFR and TS enzymes. We also consider the
opportunities the cloned gene may provide for further study.
MATERIALS AND METHODS
Parasite INA. P. falciparum strain FCR3 (7) was the
source of parasite DNA. Genomic DNA was purified from in
vitro cultured trophozoite and schizont stage parasites (7).
Oligonucleotides. A 29-base oligonucleotide mixture 5'
d[GG(A or T)(G or C)T(A or T)CC(A or T)TTTAATAT(A or
T)GC(A or T)(A or T)(G or C)(A or T)TATGC] 3', was
synthesized. The oligonucleotides corresponded to a TS
consensus sequence, Gly-(Val or Leu)-Pro-Phe-Asn-Ile-Ala-
Ser-Tyr-Ala (11). Radioactively end-labeled oligonucleotides
(12) hybridized with a 3.5-kilobase (kb) EcoRI fragment on
Southern blots (13) of restriction enzyme-digested P. falci-
parum DNA (data not shown).
Construction and Screening of Genomic DNA Libraries.
Genomic DNA libraries were constructed in Xgtll (14) as an
EcoRI library and in XZAP (Stratagene Cloning Systems, San
Diego, CA) as an Xba I library. Bacteriophage were grown in
Escherichia coli strains Y1088 (15) or XL-1 blue (Stratagene).
Recofmbinant phageDNA was transferred to nitrocellulose as
described (12). Genomic DNA fragments were labeled by the
oligo-labeling method (16). Hybridization conditions were as
described (7). Southern blotting was performed using Zeta
probe membranes (Bio-Rad) (17).
Subcloning and DNA Sequencing. EcoRI fragments from
Xgtll recombinants were subcloned into plasmid pUC18 (18).
XZAP recombinants were made into plasmid recombinants
by automatic excision (Stratagene). DNA fragments were
sequenced using dideoxynucleotide technology (19). Briefly,
DNA fragments were purified (20), self-ligated, and sonicated
(21). The ends of 0.3- to 0.7-kb DNA fragments were
enzymatically repaired (blunted) and cloned into Sma I-
digested, alkaline phosphatase-treated M13mp8 (22). The
DHFR-TS sequence reported here was determined from over
40 kb of randomly derived sequence data. Every base pair in
the DHFR-TS coding region was sequenced '10 times
(average), and both DNA strands were completely se-
quenced. DNA sequences were reconstructed using theDNA
Inspector II programs (23) (a gift of Textco, West Lebanon,
NH). The BIONET computer resource for molecular biology
(IntelliGenetics, Palo Alto, CA) was used to manipulate DNA
sequences and to predict protein secondary structure (24).
RESULTS
Genomic DNA Cloning. Four Xgtll recombinant phage
were isolated from the P. falciparum genomic EcoRI library
that was screened with the oligonucleotide probe. These
phage each contained a single 3.5-kb EcoRI fragment of P.
falciparum DNA. One of them, Xgtll-TS4a, was sequenced
(see below). A sequence beginning at the 5' left end of that
EcoRI fragment encoded 138 amino acids that corresponded
to sequences in other TS genes (Fig. 1 c and d) (11). The TS4a
clone, a 267-base-pair EcoRI/Dra I fragment contained
within the TS4a clone, the clones DHFR X7, DHFR El, and
DHFR E5 (see below) were used to establish the restriction
map of genomic DNA (Fig. 1 a and b) in Southern blotting
experiments (data not shown). We were unable to isolate the
entire DHFR-TS gene on a single 16-kb Bcl I DNA fragment
Abbreviations: TS, thymidylate synthase; DHFR, dihydrofolate
reductase; Pyrr, pyrimethamine resistant.
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FIG. 1. The restriction map and genomic DNA clones of the DHFR-TS gene. (a) Restriction sites shown are A, BamHI; C, Bcl I; B, Bgl
II; E, EcoRI; H, HindIII; K, Kpn I; P, Pst I; L, Sal I; S. Spe I; T, Sst I; X, Xba I. The Dra I site (D) was determined by DNA sequencing.
(b) Enlarged restriction map encompassing DHFR-TS. (c) The large open reading frame encoding the DHFR-TS is indicated. The site that
corresponds to the binding site for the oligonucleotides is indicated. (d) Genomic DNA clones used in the determination of the DHFR-TS
nucleotide sequence. Solid portions indicate P. falciparum DNA, and open portions indicate deletions of P. falciparum DNA (see text).
(Fig. la) because of the instability of those clones in several TS clones from cDNA libraries prepared from tropho-




30 40 50 60
GAGGGGAAAAAAAATGAGGTTTTTAATAACTACACATTTAGAGGTCTAGGAAATAAAGGAGTATTACCATGGAAATGTAATTCCCTAGATATGAAATATTTTTGTGCAGTTACAACATAT 2 40
GluGlyLysLysAsnGluValPheAsnAsnTyrThrPheArgGlyLeuGlyAsnLysGlyValLeuProTrpLysCysAsnSerLeuAspMetLysTyrPheCysAlaValThrThrTyr
70 80 90 100
GTGAATGAATCAAAATATGAAAAATTGAAATATAAGAGATGTAAATATTTAAACAAAGAAACTGTGGATAATGTAAATGATATGCCTAATTCTAAAAAATTACAAAATGTTGTAGTTATG 360
ValAsnGluSerLysTyrGluLysLeuLysTyrLysArgCysLysTyrLeuAsnLysGluThrValAspAsnValAsnAspMetProAsnSerLysLysLeuGlnAsnValvalvalMet
110 120 130 140
GGAAGAACAAACTGGGAAAGCATTCCAAAAAAATTTAAACCTTTAAGCAATAGGATAAATGTTATATTGTCTAGAACCTTAAAAAAAGAAGATTTTGATGAAGATGTTTATATCATTAAC 480
GlyArgThrAsnTrpGluSerIleProLysLysPheLysProLeuSerAsnArgIleAsnValIleLeuSerArgThrLeuLysLysGluAspPheAspGluAspValTyrIleIleAsn
150 160 170 180
AAAGTTGAAGATCTAATAGTTTTACTTGGGAAATTAAATTACTATAAATGTTTTATTATAGGAGGTTCCGTTGTTTATCAAGAATTTTTAGAAAAGAAATTAATAAAAAAAATATATTTT 600
LysValGluAspLeuIleValLeuLeuGlyLysLeuAsnTyrTyrLysCysPheIleIleGlyGlySerValValTyrGlnGluPheLeuGluLysLysLeuIleLysLysIleTyrPhe
190 200 210 220
ACTAGAATAAATAGTACATATGAATGTGATGTATTTTTTCCAGAAATAAATGAAAATGAGTATCAAATTATTTCTGTTAGCGATGTATATACTAGTAACAATACAACATTGGATTTTATC 7 20
ThrArgIleAsnSerThrTyrGluCysAspValPhePheProGluIleAsnGluAsnGluTyrGlnIleIleSerValSerAspValTyrThrSerAsnAsnThrThrLeuAspPheIle
230 240 250 260
ATTTATAAGAAAACGAATAATAAAATGTTAAATGAACAAAATTGTATAAAAGGAGAAGAAAAAAATAATGATATGCCTTTAAAGAATGATGACAAAGATACATGTCATATGAAAAAATTA 840
IleTyrLysLysThrAsnAsnLysMetLeuAsnGluGlnAsnCysIleLysGlyGluGluLysAsnAsnAspMetProLeuLysAsnAspAspLysAspThrCysHisMetLysLysLeu
270 280 290 300
ACAGAATTTTACAAAAATGTAGACAAATATAAAATTAATTATGAAAATGATGATGATGATGAAGAAGAAGATGATTTTGTTTATTTTAATTTTAATAAAGAAAAAGAAGAGAAAAATAAA 960
ThrGluPheTyrLysAsnValAspLysTyrLysIleAsnTyrGluAsnAspAspAspAspGluGluGluAspAspPheValTyrPheAsnPheAsnLysGluLysGluGluLysAsnLys
310 320 330 340
AATTCTATACATCCAAATGATTTTCAAATATATAATAGCTTGAAATATAAATATCATCCTGAATACCAATATTTAAATATTATTTATGATATTATGATGAATGGAAATAAACAAAGTGAT 10 80
AsnSerIleHisProAsnAspPheGlnIleTyrAsnSerLeuLysTyrLysTyrHisProGluTyrGlnTyrLeuAsnIleIleTyrAspIleMetMetAsnGlyAsnLysGlnSerAsp
350 360 370 380
CGAACGGGAGTAGGTGTTTTAAGTAAATTCGGATATATTATGAAATTTGATTTAAGTCAATATTTCCCATTATTAACTACGAAGAAATTATTTTTAAGAGGAATTATTGAAGAATTGCTT 1200
ArgThrGlyValGlyValLeuSerLysPheGlyTyrIleMetLysPheAspLeuSerGlnTyrPheProLe LeuThrThrLysLysLeuPheLeuArgGlyIleIleGluGluLeLeu
390 400 4-10 420
TGGTTTATTAGAGGAGAAACAAATGGTAATACGTTGTTAAATAAGAATGTAAGGATATGGGAAGCTAATGGTACTAGGGAATTTTTAGATAATAGAAAATTATTTCATAGAGAAGTTAAC 1 320
TrpPheIleArgGlyGluThrAsnGlyAsnThrLeuLeuAsnLysAsnValArgIleTrpGluAlaAsnGlyThrArgGluPheLeuAspAsnArgLysLeuPheHisArgGluValAsn
430 440 450 460
GATTTAGGACCTATTTATGGTTTTCAATGGAGACATTTCGGTGCTGAATATACAAATATGTATGATAATTATGAAAATAAAGGAGTGGATCAATTAAAAAATATAATAAATTTAATTAAA 1440
AspLeuGlyProIleTyrGlyPheGlnTrpArgHisPheGlyAlaGluTyrThrAsnMetTyrAspAsnTyrGluAsnLysGlyValAspGlnLeuLysAsnIleIleAsnLeuIleLys
470 480 490 500
AATGATCCTACAAGTAGAAGAATTCTTTTGTGTGCATGGAATGTAAAAGATCTTGACCAAATGGCATTACCTCCTTGTCATATTTTATGTCAGTTTTATGTTTTCGATGGGAAATTATCA 1560
AsnAspProThrSerArgArgIleLeuLeuCysAlaTrpAsnValLysAspLeuAspGlnMetAlaLeuProPrcE HisIleLeuCysGlnPheTyrValPheAspGlyLysLeuSer
510 520 530 540
TGTATTATGTATCAAAGATCATGTGATTTAGGGCTAGGAGTACCTTTTAATATTGCTTCTTATTCTATTTTTACTCATATGATTGCACAAGTCTGTAATTTGCAACCTGCGCAGTTCATA 1680
CysIleMetTyrGlnArgSerCysAspLeuGlyLeuGlyValProPheAsnIleAlaSerTyrSerIlePheThrHisMetIleAlaGlnValCysAsnLeuGlnProAlaGlnPheIle








FIG. 2. The DNA sequence encoding the P. falciparum DHFR-TS. The predicted amino acid sequence of DHFR-TS is shown below the
codons. The nucleotide sequence shown includes 48 bases of 5' noncoding DNA and 285 bases of 3' noncoding DNA. The first amino acid
residue, Met, is specified by nucleotide numbers 50-52. Nucleotides are numbered in the right column and amino acids are numbered above
the codon and amino acid residue. Boxed amino acid residues 369-383 correspond to the proposed folypolyglutamate binding site (see text) and
the boxed Cys amino acid residue 490 corresponds to the probable nucleophilic catalyst in the conversion of dUMP to dTMP (see text). The
underlined nucleotides correspond to the hybridization site of the oligonucleotides.
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We therefore screened a P. falciparum Xba I library to insertions. They had deletions of 3.6 kb and 3.0 kb, which
isolate the genomic 4.9-kb Xba I fragment (Fig. 1 a and b). A were, respectively, between (TTTA)" repeat sequences and
clone (DHFR X7; Fig. ld) that contained a 2.1-kb Xba I (AT),, repeat sequences. Difficulties in cloning other P.
fragment was isolated, and the DHFR X7 fragment was falciparum genes may be related to the presence of similar
sequenced (see below). It contained an additional DHFR-TS repeat sequences. All the cloned fragments containing DHFR-
coding sequence and a 2.8-kb deletion (Fig. ld). To clone the TS coding sequences are shown (Fig. ld).
5' portion of the coding sequence of the gene, we screened the DNA Sequence Analysis and Sequence Properties. We se-
Xgtll EcoRI library with the 1.0-kb BgI II fragment from the quenced the following DNA fragments (Fig. 1): the 3.5-kb
DHFR X7 clone so as to isolate a recombinant that contained EcoRI fragment of Xgtll TS4a; the 5' 1.0-kb Xba I/Bgl II
a 5.4-kb genomic EcoRI fragment (Fig. 1 a and b). Two phage fragment of DHFR X7; the 5' 0.8-kb EcoRI/Bgl II fragment
that were isolated and purified, designated DHFR El and of DHFR El; and the 5' 1.4-kb EcoRI/Bgl II fragment of
DHFR E5 (Fig. ld), respectively, had 1.8-kb and 2.4-kb DHFR E5. The DNA sequence of the DHFR-TS gene is
Dihydrofolate Reductase
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LI DGH HLPDDLH . R A Q . T .V
T4..............MIKLVE.NSPTK....TVDGFNELAF.G G.. EPRV`KKDLQ
................
100 110 120 130 140 150 160 170 180
PF SKKLQNVVV TNW IPKKFK LSRINVILS..... RTLKKEDFDED........ VYIINKVEDLIVLLGKLNYY .... KCFII VVYQEFL ... EKKLIKKIYF
LM TEKKRNAVV KTW PVKFR K NIVLSSKATVEELLAPLPEGQRAAAAQDVWVVNGGLAEALRLLARPLYCSS IETAYCV QVYADAMLSPC IEKLQEVYL
H VEGKQNLVI KKTW IPEKNR INLVLS
..... RELKEPPQG.........AHFLSRSLDDALKLTEQPELANKVDMVWIV SVYKEAM... NHPGHLKLFV
EC ..NKPVI HTW IG..*.R P NIILS...SQP.GTDDR......VTWVKSVDEAIAACGDVP....EIMVI RV`YEQFL....PKAQKLYL
LC GKIMV RTY P.. KR P NV`VLT....HQEDYQAQG......AVVVHDVAAVFAYAKQHLDQ....ELVIA QIFTAFK....DVDTLLV
T4
...
.GTIMI KTF LP.. T P HIVVC....DL.ARDYP......VTKDGDLAHFYITWEQYI.....TYI EIQVSSP. ..NAPFETMLDQ
190 00 220 230 240 250 260 270 280
PF TRINSTYECDV.FFPEINENEYQIISV ..... SDVYTSNN... TTLDFIIYKKTNNKMLNEQNCIKGEEKNNDMPLKNDDKDTCHMKKLTEFYKNVDKYKINYENDDDDE
LM TRIYATAPACTRFFPFPPENAATAWDLASSQGRRKSEAEGLE
.....FEI.CKYVPRN.
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290 300 310 320 330 340 350 360 370 380
PF EEDDFVYFNFNKEKEEKNKNSIHPNDFQIYNSLKYKYHPEY LNIIYDIMM KQS...... VGVLSKFGYIMKFDLSQY. E~ TJKLFLRGIIELLM.H ER LELIDRIMK1IGhI VKE.......... VGTISLFGAQMRFSLRDNRLL TKVFWRGVC E ELLH MPVAGSELPRRPLPPAAQERDAEPRPPHGEL LGQIQHILR ~IRKD...... TGTLSVFGMQARYSLRDE. FELT VFWKGVLEIELLM MLVVGSEL.....QSDAQQLSAEA. PRHGEL YILRQVEHILRCG KKE.......... TGTLSVFGMQARYSLRDE. EeL T VFWKGVLEIEL L
HVS MSTHTEEQHGEH YLSQVQHILN GFKN.......... TGTLSIFGTQSRFSLENE. EIPIL TRVFWRGVV ELL
VZV MGDLSCWTKVPGFTLTGEL KQVDDILR RKR...... IGTLSLFGMQARYNLRNE.~ T VFWRAV EL
EC MK ELMQKVLD QKN.C.F.I GTGTLSIFGHQMRFNLQDG. T CHLRSII EL
LC MLEQ DLAKKVLD FKP.D.E.I HTGTYSIFGHQMRFDLSKG. LLTVPFGLIK EL
T4 MK QDLIKDIFE ETD...... TGTIALFGSKLRWDLTKGF TLAWKACI I
*3T MTQFDK NSIIKDIIN ISDEEFDVRTKWD PAHTLSVMSKQMRFDNSE.. I T VAWKTAI
390 400 410 420 0 440
PF *IRGET.NGNT LNKN.....VRIIEANGTREFLDNRKLFHREV
.................. :ND~I RHFGAEYTNMYDNYLM IFLRGET.SAQL DKD....... IH ]GNGSREFLDSRGLTENKE
............................ MD V Y RHFGADYKGFEANY
H IVF.IKGST.NAK SSKG.......VK DANGSRDFLDSLGFSTREE GD YG RHFGAEYRDMESDY
M 1 IKGST.NAKE:E:SSKG.......VR DANGSRDFLDSLGFSARQE ............................... GDE Y RHFGAEYKDMDSDY
HVS >F IRGST.DSK AAG.......VH DANGSRSFLDKLGFYDRDE............................... GDE Y RHFGAEYKGVGRDY
VZV FIRGST .DSKEEAKD ..................IHDI IYGSSKFLNRNGFHKRHT ................................... GD EG IYRHFGAEYKDCQSNY
EC > LQGDT.NIA YHENN .......VT EW D N.....................VTDWEN..............................GD tG \GKCRAWPTP.. . .
LC LHGDT.NIR LQHR........NH EWAFEKWVKSDEYHGPDMTDFGHRSQKDPEFAAVYHEEMAKFDDRVLHDDAFAAKYGD V RAWHTS .
... ...
T4 LSGST.NVN RLIQHDSLIQGKT ENYENQAKDLGYHS
..........................................
GE I RDFG.
03T *WQLKSNDVTE[KMG .......VH Q KE . ............................................... GTI EAY _ GKKNRS ..............L
450 470 480 490 500 510 520 530 5 550
PF ENKG KNIINLI ILLC KDLD IL Y D. . CIMY FAS IFTHMI VCNLQPAQFIHV A N
LM DGEG IKLI VETI N LLVT PCALQ PHLL Y TOTS CMLY FAS LLTIL KATGLRPGELVHT R
H SGQG LQRVIDTI D R IIMC PRDLP P HAL N. .S CQLY IF AS LLTYMI ITGLKPGDFIHT I
M SGQG LQKVIDTI DR IIMC PKDLP P HAL N. .G SCQLY F IAS LLTYM ITGLQPGDFVHT I L
HVS KGEG LKQLIDTI T LMC SDIP HVL . .G CQLY F IAS LLTCM VTNLVPGEFIHTI AIV
VZV LQQGICLQTVIDTI E RI IS KDIP P HTL N. ..G CQVY F IAG LLTYI VTGLKTGDLIHT I L
EC DGRHID ITTVLNQL D IIVS WGELD A HAF D. .G CQLY F IAS LLVHM QCDLEVGDFVWT YTS
LC KGDTID GDVIEQ T Y R LIVS PEDVP P HTL ND.. G LQLY FIF AS LLTHL ECGLEVGEFIHTF
T4 . . .G I EVIDRI K N R IVS PAELK P HMF RN..NG LQWY FLAS TLVHI KMCNLIPGDLIFS I
43T NGEK DYLLHQ N S ITM PODLO VYE KQ. . LEVR F FQ VLQRM VTGYELGEYIFNI C
560 570 580 590 600
PF IDSLKIQLNtfIPYPFP iKLNPDIKNIEDF ........ TITIQNVHHEKISMDA
LM VDALKAQL 4VPHAFPILIFKEERQYLEDY..... . EL EVIEIVPHPAIKMEV
H IEPLKIQL EPRPFPIRILRKVEKIDDF ..........KA QIE YpPHPTIKMEV
M IEPLKIQL EPRPFP KKILRKVETIDDF ............ KV QI EqYl PHPTIKME V
HVS IDALKMQLr PRPFP [1RFARNVSCIDDF ............ KA IILEN PHPIIKMH V
VZV IDALKVQLwPKPFP KIIRNVTDINDF ............ KW QLD PHPPLKME L
EC MDQTHLQL PRPLP IIKRKPESIFDY ...... RF EIE PHPGIKAP I
LC LDQIKEQL PRPAP QLNPDKHDIFDF ...... DM IKLL PYPAIKAP V
T4 VEQCKEIL PKELC ISGLPYKFRYLSTKEQLKYVLKLRP VLN SHPPIKGKV
¢3T IDNLKIQM QFEAP INPEVKDFYNF ............TV KLI HGDKLLFE
FIG.3. Comparison of the primary structure of P.falciparum DHFR-TS with enzymes from other sources. The enzymes were DHFR (amino
acids 1-228), junctional sequence (amino acids 229-322), and TS (amino acids 323-608). EC, Escherichia coli (27, 28); HVS, Herpesvirus saimiri(29); H, Homo sapiens (human) (30-32); LC, Lactobacillus casei (33, 34); LM, Leishmania major (35); M, mouse (36); T4, phage T4 (37, 38);43T, phage 43T (39); PF, P. falciparum; VZV, varicella zoster virus (40). The sequence of the Leishmania tropica DHFR-TS (11) is nearly
identical to the L. major sequence and was not used in the alignment. Boxes show locations of invariant amino acids. Amino acids are identified
by the single-letter code.
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shown (Fig. 2). The sequence begins in the (AT), ladder in the
5' noncoding region of the gene. The location to which the
oligonucleotides hybridized is underlined. A single long open
reading frame began at the AUG codon at nucleotide 49 and
ended at the UAA stop codon at nucleotides 1873-1875. No
intervening sequences were identified. The assigned reading
frame was based on homology of the predicted amino acid
sequence to other known DHFR-TS gene sequences (see
below). The primary DHFR-TS protein contained 608 amino
acids and had a calculated molecular mass of 71,682 Da,
which corresponded with the measured mass of 70 kDa (7)
and was higher than the 63 kDa previously reported (9).
The coding sequence for the DHFR-TS gene resembled all
known P. falciparum coding regions (25) in that (i) it had a
lower A+T content (75%) than the flanking sequences [94%
(5') and 87% (3')]; (ii) the mRNA sense strand had a higher
A (41%) than T (34%) content; (iii) the A+T content of the
first three coding positions increased in that order (65%, 76%,
and 84%); (iv) the S value (26), 16.3, a measure of codon
preference, was nearly identical to the average value of 16.2
for P. falciparum coding regions (25).
Protein Homology. The alignment of the protein sequence
of P. falciparum DHFR-TS was based on the locations of
invariant amino acids and the structural equivalence of the
proteins in those enzymes from other organisms (Fig. 3).
While all invariant amino acids ofDHFR and TS are indicated
(Fig.3), the many conservative amino acid changes were not
indicated. The P. falciparum protein contained three struc-
tural domains: an amino-terminal DHFR domain (-27 kDa),
a junctional domain (-11 kDa), and a carboxyl-terminal TS
domain (=34 kDa).
DHFR Homology. We defined the DHFR domain to include
amino acids 1-228 based on both amino acid homology and
predictions of secondary structure of the DHFR enzymes
(see below). The P. falciparum DHFR domain had little
amino acid homology to other forms ofDHFR in amino acids
1-10 and 201-228, while amino acids 11-200 had significant
homology except for several amino acid insertions (Fig. 3).
Eleven amino acids were invariant between all forms and
35 other amino acids were conserved between four or more
of the different forms of DHFR (Fig. 3). Many of these
conserved amino acids are thought to participate in substrate
binding (41). The P. falciparum DHFR domain was most
homologous to the two eukaryotic ["vertebrate" (11, 41)]
forms of DHFR, sharing 61 amino acids with the human
DHFR and 56 amino acids with L. major (Table 1). Eukary-
otic DHFR could be distinguished from prokaryotic (and
prokaryotic viral) DHFR by amino acid insertions that form
loops connecting elements of secondary structure (11, 41).
On the basis of insertions and amino acid homology, the P.
falciparum enzyme resembled the eukaryotic form ofDHFR
(Fig. 3; Table 1).
Secondary structures in other DHFRs were also conserved
in the P. falciparum enzyme (41). The conserved eight
prominent 13-strands (designated pA-,BH) found in all forms
of DHFR except L. tropica (11) were predictable in the P.
Table 1. Numbers of amino acids shared by different DHFRs
PF LM H EC LC T4
PF 228 56 61 47 38 24
LM 226* 59 48 40 24
H 186 47 42 29
EC 159 43 34
LC 162 32
T4 193
The alignments used to calculate shared amino acids are shown in
falciparum DHFR domain (amino acids 1-228). The ,3-
strandsBA-pF, involved in substrate binding, were identified
in the first 188 amino acids. The four a-helices found in other
forms of DHFR were predictable in P. falciparum. The
eukaryotic-specific aE' helix, however, was not predictable
in the P. falciparum DHFR.
TS Homology. We defined the TS domain to include amino
acids 323-608 based on amino acid homology and secondary
structure of other TS enzymes (see below). The P. falci-
parum TS domain was very homologous to eukaryotic forms
of the TS enzyme based on amino acid homology (Fig. 3;
Table 2). The two protozoan enzymes shared fewer amino
acids with each other than either enzyme did with the human
TS (Table 2). While the two protozoan enzymes shared 153
amino acids, these were encoded by 75% A+T-rich DNA in
P. falciparum compared with 38% A+T-rich DNA for L.
major (35).
Fifty-one invariant amino acids occurred between the 10
characterized forms of TS. At 137 locations, seven or more
amino acids out of 10 were identical. Between the 10 forms
of TS, there was -68% amino acid homology if amino acid
insertions were disregarded. Many of the amino acid changes
were conservative and revealed a remarkable overall chem-
ical homology. Conservation of structural elements through-
out the TS domain was therefore implied.
Eight sites of amino acid insertions in all TS occurred
outside of predicted structural elements and represented
loops in domains that probably do not influence the core
structure (42). The amino acid insertions in the P. falciparum
enzyme were identical in size in all eukaryotic forms except
for L. major. The P. falciparum enzyme was most homolo-
gous to the eukaryotic enzymes based on both amino acid
homology and insertions (Fig. 3; Table 2).
The P. falciparum TS domain contained essentially all of
the elements found in the three-dimensional structure of the
L. casei TS enzyme (42). The five ,8-strands (,Bi-e3v), which
formed the dimer interface in the L. casei TS, were present
and 10 of the 11 a-helices were predicted. The corresponding
a-C helix in P. falciparum was not predicted and had a weak
a-helical nature due to the presence of several Asn and Gly
residues (amino acids 392, 393, 394, 398, and 400).
Amino acids 370-372 were invariant and formed part of the
sequence identified as binding folate cofactors (Fig. 3) (43).
The Lys (amino acid 372) and Lys or Arg (amino acid 373) are
thought to play a role in binding folypolyglutamate (42, 43).
The three-dimensional structure ofTS from L. casei led to the
assignment of amino acids that form the active site and the
elements of structure thought to be important in the activities
of the enzyme (42). The Cys at amino acid 490 (Fig. 3) is the
probable binding site for FdUMP and dUMP (27, 37, 42, 44)
and has been proposed as the essential nucleophilic catalyst
Table 2. Numbers of amino acids shared by different TSs
PF LM H M HVS VZV EC LC T4 43T
PF 286* 153 161 161 160 142 115 127 114 102
LM 289* 174 174 172 161 124 133 116 97
H 313 279 207 204 141 139 128 104
M 307 205 205 142 139 126 105
HVS 294 192 130 148 113 107
VZV 301 124 138 120 101
EC 264 156 126 95
LC 316 122 104
T4 286 90
43T 279
The alignments used to calculate shared amino acids are shown in
Fig. 3. Organisms (and abbreviations) used for comparison are shown
in Fig. 3.
*Based on the TS domain starting at P. falciparum amino acid 323 in
Fig. 3.
Fig. 3. Organisms (and abbreviations) used for comparison are shown
in Fig. 3.
*Includes DHFR and junctional amino acids.
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in conversion of dUMP to dTMP (11, 42). That Cys is
embedded within a highly conserved sequence Met-Ala-(Leu
or Val)-Leu-(Pro or Ala or Thr)-Pro-Cys-(His or Val).
Junctional Sequence. We defined amino acids 229-322 as a
junctional sequence joining the DHFR and TS domains. They
had essentially no homology to DHFR or TS enzymes of
other organisms (Fig. 3). The A+T content of this sequence
(81%) is higher than the DHFR domain (75%) and TS domain
(73%). This sequence contained 41 charged amino acids and
33 hydrophilic amino acids. A secondary structure analysis
predicted a random coil structure for most of this sequence.
The junctional sequence resembled that of L. major with
respect to having many charged and hydrophilic amino acids
and random coil structure, although the L. majorjunction (37
amino acids) was smaller (35).
DISCUSSION
The successful cloning and sequence analysis of the P.
falciparum DHFR-TS gene now permits a careful examina-
tion of pyrimethamine resistance. One Pyrr mutant (5, 7) had
a gene duplication of DHFR-TS sequence and a dispropor-
ti nate overroduction ofthe DHFR-TS protein (7). Study of
that gene may provide insight into regulation of the enzyme's
synthesis. A known mutant DHFR [FCR3-D8 (5, 7)] that
confers a high level of parasite drug resistance could be used
as a selectable genetic marker for establishing a parasite gene
transformation system. Such a system would be invaluable to
further analyze other forms of drug resistance and to study
parasite antigens that play a role in inducing natural parasite
immunity.
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